SCR7 PYRAZINE

SCR7 PYRAZINE

Stock Code: 3575063
Manufacturer Part No: SML1546-25MG
Order Now for 7 day delivery
£571.07 (exc VAT) per 25MG
Quantity: - +

Application


SCR7 pyrazine has been used as a non-homologous end joining (NHEJ) modulator to study its effect on CRISPR/Cas9-mediated editing.


SCR7 pyrazine has been shown to enhance CRISPR genome editing efficiency. To see other small molecule CRISPR enhancers, visit sigma.com/CRISPR-enhancers.


Biochem/physiol Actions


SCR7 pyrazine is reported to be an inhibitor of non-homologous end joining (NHEJ) and has been shown to enhance the efficiency of CRISPR-Cas9 genome editing. The effect of SCR7 pyrazine on the efficiency and targeting precision of CRISPR applications has been shown to be cell type specific and context dependent. SCR7 pyrazine is a product of spontaneous cyclization of SCR7, first reported by Srivastava, M., et al.


General description


SCR7 pyrazine is an inhibitor of DNA ligase IV.


Packaging


5, 25 mg in glass bottle

Colourfaintly yellow to dark yellow
Quality Level100
InChI keyGSRTWXVBHGOUBU-UHFFFAOYSA-N
InChI1S/C18H12N4OS/c23-17-15-16(21-18(24)22-17)20-14(12-9-5-2-6-10-12)13(19-15)11-7-3-1-4-8-11/h1-10H,(H2,20,21,22,23,24)
ManufacturerSIGMA-ALDRICH
SolubilityDMSO: 10 mg/mL, clear
Formpowder
Assay≥98% (HPLC)

There are no downloads for this product.